Renal Medullary Carcinoma



Renal Medullary Carcinoma


Satish K. Tickoo, MD

Victor E. Reuter, MD










The photograph demonstrates the gross appearance of a renal medullary carcinoma. The tumors, particularly the smaller ones, are renal medulla based, with infiltrative borders image. Here, it also invades the renal pelvis image.






Renal medullary carcinoma often shows a mixture of architectural patterns, reticular and cribriform patterns being the most common. The tumor invariably shows high nuclear grade.


TERMINOLOGY


Abbreviations



  • Renal medullary carcinoma (RMC)


Synonyms



  • Medullary renal cell carcinoma (RCC)


Definitions



  • Distinctive clinicopathologic entity occurring almost exclusively in patients with sickle cell trait



    • Rare cases in patients with hemoglobin SC disease and very occasionally in sickle cell disease (SS)


ETIOLOGY/PATHOGENESIS


Sickle Cell Hemoglobinopathies



  • Presence of HbS in virtually all cases, suggesting some cause-effect relationship between hemoglobinopathy and this tumor



    • Exact mechanism unknown; role of tissue hypoxia and hypoxia-inducible factor (HIF) in tumorigenesis or tumor viability/tumor progression is suggested


INI1(hSNF5/BAF47)



  • Loss of immunohistochemical nuclear expression of SNF5 (INI1) protein, similar to pediatric rhabdoid tumor of kidney, is consistent finding



    • Molecular mechanism, i.e., mutations/loss of gene or others, for this absent SNF5 expression is not known


ABL-BCR Amplifications



  • Amplification of both ABL and BCR genes described in few cases


  • ABL-BCR translocation described in 1 case but not in 3 others tested


Relationship to Collecting Duct Carcinoma



  • Some consider RMC to be a particularly aggressive form of collecting duct carcinoma


CLINICAL ISSUES


Epidemiology



  • Incidence



    • Very uncommon tumor


  • Age



    • Range: 5-39 years; only occasionally in older patients


  • Gender



    • Predominantly male, especially in patients < 25 years old


  • Ethnicity



    • Mostly African-American; occasionally of Mediterranean ancestry, rarely others


Presentation



  • Often with hematuria or flank pain, and many presenting with symptoms related to metastases


Laboratory Tests



  • Most with sickle cell trait (Hb-AS) or Hb-SC on hemoglobin electrophoresis


  • Rarely with homozygous sickle cell anemia (Hb-SS)


Prognosis



  • Biologic behavior very aggressive; mean survival approximately 4 months; most cases with metastases at presentation


MACROSCOPIC FEATURES


General Features



  • Medullary-based, gray-white cut surface, infiltrative borders often with extension into perihilar fat



  • Satellite nodules in adjacent parenchyma frequently observed



    • Often representing tumor emboli in large vessels


MICROSCOPIC PATHOLOGY


Histologic Features



  • Most common architectural features: Reticular or cribriform glands



    • Other patterns include yolk sac-like, glandular, solid nests, and tubules; undifferentiated sheet-like or adenoid cystic-like


  • Stroma almost always fibrotic or desmoplastic, and intratumoral inflammatory infiltrate, mostly neutrophils, is very frequent


  • Tumor margins always infiltrative


  • Cytoplasmic mucin is commonly observed


  • Cytology usually high grade, with moderate to marked nuclear atypia



    • Occasional cases with rhabdoid features


  • Sickled RBCs frequently observed, both within tumor and surrounding renal parenchymal vessels


  • Often with high pT and pN stage and satellite tumor nodules due to very frequent vascular spread


Predominant Pattern/Injury Type



  • Neoplastic


Predominant Cell/Compartment Type



  • Epithelial


DIFFERENTIAL DIAGNOSIS


Collecting Duct Carcinoma



  • Medullary carcinoma believed by some to be particularly virulent variant of collecting duct carcinoma


  • No hemoglobinopathy


  • Usually HMCK(34βE12) positive

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 7, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Renal Medullary Carcinoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access